Publication | Closed Access

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationImmunologyHematologyTk007 TrialGraft SurvivalStem Cell TherapiesCell TransplantationMedicineCell BiologySuicide-gene-engineered Donor Lymphocytes